Carolina Contreras Cuevas/LinkedIn
Oct 24, 2025, 10:03
Debunking Myths with Carolina Contreras Cuevas: The AQUARIUS Trial That Had to Be Stopped
Carolina Contreras Cuevas, Hematologist, Medical Center and Interconsultant Physician at RedSalud CCHC, shared a post on LinkedIn:
“Debunking Myths.
The AQUARIUS study on the use of ASA + anticoagulant (VKA or DOAC) in patients with chronic coronary syndrome, already with a stent implanted for >6 months, and on anticoagulation for another reason.
Spoiler: The study had to be stopped early at 2.2 years.”
Read full paper here.
Stay informed with Hemostasis Today.
-
Nov 15, 2025, 15:47Shannon Farmer: Congratulations to Susan Goobie and Colleagues on Publication of Their Important Study
-
Nov 15, 2025, 15:46Fotios Barkas: Explore the Latest Articles From the Journal of Atherosclerosis Prevention and Treatment!
-
Nov 15, 2025, 15:45Ludovic Helfgott: Researchers Have Analysed Novo Nordisk Product Data in Obesity and Cardiovascular Disease
-
Nov 15, 2025, 15:42Haroun Gajraj Thanks Enric Roche for Demonstrating the Piston Effect
-
Nov 15, 2025, 15:41Thrombectomy Rates Rise 700% Nationwide
-
Nov 15, 2025, 15:41Emmanuel J. Favaloro: Transitioning Patients from DOACs to Heparin
-
Nov 15, 2025, 15:40Bruno Lima: I Owe a Lot of My Career to Dr. Brad Maron
-
Nov 15, 2025, 15:39Ramesh Balasubramanian: Future of Hematology is Encouraging. Striving Towards More Cure for the Dreaded Cancer
-
Nov 15, 2025, 15:37Atrial Fibrillation Increases the Risk of Stroke by Up to Fivefold Due to Clot Formation in the Atria